These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 17687216)
21. [A case of advanced colon cancer with metastases to both the Virchow's and the paraaortic lymph nodes that achieved complete long-term response with levofolinate.5-FU therapy]. Mio H; Yamada T; Sekiya M; Maruyama H; Kathou T Gan To Kagaku Ryoho; 2004 Mar; 31(3):423-6. PubMed ID: 15045954 [TBL] [Abstract][Full Text] [Related]
22. [A case of esophageal cancer associated with colon cancer successfully treated with combination chemotherapy of FOLFOX and concurrent radiotherapy]. Watanabe Y; Tsutsui M; Takeda S; Yoshino S; Oka M Gan To Kagaku Ryoho; 2009 Nov; 36(12):2439-41. PubMed ID: 20037449 [TBL] [Abstract][Full Text] [Related]
23. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer. Liu ZF; Guo QS; Zhang XQ; Yang XG; Guan F; Fu Z; Wang MY Am J Clin Oncol; 2008 Jun; 31(3):259-63. PubMed ID: 18525305 [TBL] [Abstract][Full Text] [Related]
24. [Fifth-line chemotherapy for metastatic gastric cancer--a case responding to modified FOLFOX 6]. Sagawa T; Sato Y; Takayama T; Kuroda H; Hirakawa M; Abe S; Iyama S; Sakamaki S; Kato J; Niitsu Y Gan To Kagaku Ryoho; 2007 Sep; 34(9):1467-71. PubMed ID: 17876148 [TBL] [Abstract][Full Text] [Related]
25. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1. André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423 [TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy of advanced and recurrent colorectal cancer]. Tominaga T Gan To Kagaku Ryoho; 1986 Jul; 13(7):2298-306. PubMed ID: 3488029 [TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin (Eloxatin) for advanced colon cancer. Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541 [No Abstract] [Full Text] [Related]
28. [A case of advanced colon cancer responding completely to systemic 5-fluorouracil/l-leucovorin therapy]. Mizushima T; Sando K; Ito T; Mikata S; Nonaka K; Ide H; Michiura T; Kainuma S; Yamanaka H; Iwase K Gan To Kagaku Ryoho; 2004 Nov; 31(12):2047-9. PubMed ID: 15570938 [TBL] [Abstract][Full Text] [Related]
29. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis. Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608 [TBL] [Abstract][Full Text] [Related]
30. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer? Twelves C Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299 [No Abstract] [Full Text] [Related]
31. Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines. Sørbye H; Dahl O J Clin Oncol; 2003 Dec; 21(23):4466-7. PubMed ID: 14645446 [No Abstract] [Full Text] [Related]
32. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer. Xiong JP; Zhang L; Zhong LX; Qiu F; Xu J; Tao QS; Xiang XJ; Yu F; Tang XM Anticancer Drugs; 2007 Oct; 18(9):1103-7. PubMed ID: 17704661 [TBL] [Abstract][Full Text] [Related]
33. [A case of recurrent rectal cancer with lymphangiosis carcinomatosa successfully treated with modified FOLFOX6 therapy]. Furuta R; Ina K; Kataoka T; Nagao S; Kayukawa S; Mori F; Masaki A; Ando T; Goto H Gan To Kagaku Ryoho; 2008 May; 35(5):849-52. PubMed ID: 18487928 [TBL] [Abstract][Full Text] [Related]
34. [A case of high CEA colon cancer responding to neoadjuvant chemotherapy with FOLFIRI]. Nakajima S; Sonoda K; Kadokawa Y; Kawabe A; Yamamoto T; Egawa H Gan To Kagaku Ryoho; 2010 Oct; 37(10):1995-8. PubMed ID: 20948272 [TBL] [Abstract][Full Text] [Related]
35. Unusual elevation of CEA in a patient with history of colon cancer. Hsu TC Jpn J Clin Oncol; 2006 Dec; 36(12):811-3. PubMed ID: 17060406 [TBL] [Abstract][Full Text] [Related]
36. [Resection of pancreatic cancer and simultaneous lung metastasis--a case report of successful in tumor dormancy mainly by postoperative 5-fluorouracil-based chemotherapy]. Baba H; Goseki N; Takamatsu S; Nosaka T; Teramoto K; Arii S; Kumagai J Gan To Kagaku Ryoho; 2002 Nov; 29(12):2382-5. PubMed ID: 12484080 [TBL] [Abstract][Full Text] [Related]
37. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145 [TBL] [Abstract][Full Text] [Related]
38. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer. Seki H; Ozaki T; Shiina M Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157 [TBL] [Abstract][Full Text] [Related]
39. [A case of recurrent colon cancer with complete response to modulation chemotherapy using low-dose leucovorin and 5-fluorouracil]. Umehara A; Kato H; Takahashi N; Endo S; Yoshimatsu K; Hashimoto M; Haga S; Kajiwara T Gan To Kagaku Ryoho; 1999 Jul; 26(8):1189-92. PubMed ID: 10431588 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients]. Young Kim W; Maeda K; Noda E; Fukunaga S; Inoue T; Kaizaki R; Shinto O; Wada K; Nakano T; Hirakawa K Gan To Kagaku Ryoho; 2007 Nov; 34(11):1833-6. PubMed ID: 18030018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]